David Delgado, MD, Awarded MACC Funding

David Delgado, MD, received $30,000 from the Midwest Athletes Against Childhood Cancer for his project, “KIR-incompatible stem cell transplantation for pediatric osteosarcoma and other pediatric solid tumors: A preclinical model.” This pre-clinical study could provide the necessary information to allow KIR-incompatible stem cell transplantation as a viable treatment option for children with metastatic, recurrent or refractory solid tumors that have been unsuccessful with previous treatment strategies.